The range of international and Australian speakers presenting at ASC 2010 reflect the theme of Molecules to Mind. The topics being addressed by our speakers extend from the molecular genetic basis of neural networks underlying complex social behaviours in schizophrenia, to neural mechanisms of cognitive and social dysfunction that point towards novel treatments and rehabilitation strategies, the science of antipsychotic drug treatment, how psychological theory, computational models and phenomenology can help us understand more fully the experience of psychosis, and how knowledge about social cognition can shape improved psychological therapies and lead to reduced stigma. Special symposia have been organised to highlight research across the Molecules to Mind spectrum, whilst a broad range of oral and poster presentations will provide the latest findings in relation to schizophrenia research and treatment.
| 08.30 – 15.30 |
Satellite Workshop
Genetics and Schizophrenia
Brain and Mind Research Institute |
| 18.00 – 20.00 |
Public Forum
Has research been of benefit to people with schizophrenia?
Garvan Institute of Medical Research |
07.00 |
Registration Desk Opens |
09.00 – 09.30 |
Welcome
Opening |
Vaughan Carr
Her Excellency Professor Marie Bashir AC CVO, Governor of New South Wales |
Grand Ballroom |
09.30 – 10.30 |
Plenary |
Understanding impaired cognition and emotion in schizophrenia
Cameron Carter, University of California at Davis, USA |
Grand Ballroom |
10.30 – 11.10 |
Plenary |
Environmental risk factors for schizophrenia: does developmental vitamin D deficiency play a role?
John McGrath, Queensland Centre for Mental Health Research |
Grand Ballroom |
11.10 – 11.30 |
Morning Tea
Level 2 Foyer |
11.30 – 13.00
|
Symposium Session 1
Timing of frontal cortex development and demise in schizophrenia
Chair: Cyndi Shannon Weickert
Ballroom 1 |
Symposium Session 2
Social cognitive deficits in schizophrenia
Chair: Cali Bartholomeusz
Ballroom 2 |
Symposium Session 3
Dissecting and treating the syndrome of schizophrenia
Chair: Brian Dean
Hyde Park Room |
13.00 – 14.00 |
Lunch
Poster Session 1 – Clinical research
Level 2 Foyer |
14.00 – 15.00 |
Chair
Plenary |
Ulrich Schall
Neuroimaging of schizophrenia: from maps to mechanisms
Andreas Meyer-Lindenberg, University of Heidelberg, Germany |
Grand Ballroom |
15.00 – 15.20 |
Afternoon Tea
Level 2 Foyer |
15.20 – 16.20 |
Oral Session 1
Animal models
Chair: Maarten van den Buuse
Ballroom 1 |
Oral Session 2
Psychosis phenotypes
Chair: Melissa Green
Ballroom 2 |
|
16.25 – 17.40 |
Oral Session 3
Epidemiology
Chair: Vera Morgan
Ballroom 1 |
Oral Session 4
Ultra-High Risk
Chair: Philip Ward
Ballroom 2 |
Oral Session 5
Pharmacology
Chair: Cherrie Galletly
Hyde Park Room |
17.40 – 19.10 |
Welcome Reception
The Conservatory Lounge & Bar, Sheraton on the Park Hotel |
07.30 |
Registration Desk Opens |
08.00 – 08.45 |
Australasian Schizophrenia Conference Business Meeting
Grand Ballroom |
09.00 – 10.00 |
Chair
Plenary |
Melissa Green
Social cognition in schizophrenia
David Penn, University of North Carolina-Chapel Hill, USA |
Grand Ballroom |
10.00 – 10.40 |
Plenary |
Functional recovery in early psychosis: Something old somewhere new
Eóin Killackey, Centre for Youth Mental Health, University of Melbourne |
Grand Ballroom |
10.40 – 11.00 |
Morning Tea
Level 2 Foyer |
11.00 – 12.45
|
Symposium Session 4
Asia-Pacific Forum
Chair: Stan Catts
Ballroom 1 |
Symposium Session 5
How animal models assist research into schizophrenia
Chair: Tim Karl
Ballroom 2 |
Symposium Session 6
Brain stimulation studies to understand function and treat symptoms of schizophrenia
Chair: Thomas Weickert
Hyde Park Room |
12.45 – 13.45 |
Lunch
Poster Session 2 – Biological research
Level 2 Foyer |
Survey of High Impact Psychosis (SHIP) Meeting
Hyde Park Room |
13.45 – 14.25 |
Chair
Plenary |
John McGrath
The nosological entity in psychiatry: An historical illusion or a real moving target?
Assen Jablensky, University of Western Australia |
Grand Ballroom |
14.25 – 14.40 |
Special Update |
Update on the Australian National Survey of High Impact Psychosis
Vera Morgan, University of Western Australia |
Grand Ballroom |
14.40 – 15.00 |
Afternoon Tea
Level 2 Foyer |
15.00 – 16.00 |
Oral Session 6
Clinical Research
Chair: Helen Stain
Ballroom 1 |
Oral Session 7
Event-related potentials
Chair: Pat Michie
Ballroom 2 |
Oral Session 8
Title: Biology to Behaviour
Chair: Ken Kirkby
Hyde Park Room |
16.05 – 17.20 |
Oral Session 9
Genetics
Chair: Murray Cairns
Ballroom 1 |
Oral Session 10
Neuropsychology
Chair: Robyn Langdon
Ballroom 2 |
Oral Session 11
Rehabilitation
Chair: Carmel Loughland
Hyde Park Room |
19.00 |
Conference Dinner
Foundation Hall, Museum of Contemporary Art, The Rocks |
08.00 |
Registration Desk Opens |
09.00 – 10.00 |
Chair
Plenary |
Cherrie Galletly
Schizophrenia, psychosis and cognition – Back to the future
Shitij Kapur, Institute of Psychiatry, King’s College, UK |
Grand Ballroom |
10.00 – 10.40 |
Plenary |
The path to developing better schizophrenia treatments
Cyndi Shannon Weickert, Schizophrenia Research Institute |
Grand Ballroom |
10.40 – 11.00 |
Morning Tea
Level 2 Foyer |
11.00 – 12.30
|
Symposium Session 7
Understanding the association between cannabis use and psychosis
Chair: Nadia Solowij
Ballroom 1 |
Symposium Session 8
Hot Topics: Late-breaking reports
Chair: Cyndi Shannon Weickert
Ballroom 2 |
Symposium Session 9
Oxidative stress and schizophrenia
Chair: Vibeke Catts
Hyde Park Room |
12.30 – 13.30 |
Lunch
Poster Session 3 – Imaging, Electrophysiology and research resources
Level 2 Foyer |
13.30 – 14.45 |
Oral Session 12
Neuro-Imaging
Chair: Christos Pantelis
Ballroom 1 |
Oral Session 13
Schizotypy, sub-phenotypes and social cognition
Chair: Carmel Loughland
Ballroom 2 |
Oral Session 14
GABA mechanisms and brain synchrony
Chair: Anthony Harris
Hyde Park Room |
14.45 |
Conference Close |
